Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02254252Phase 4Completed
A Phase 4 trial of nicorandil in Coronary Slow Flow Phenomenon (CSFP), stable angina pectoris, sponsored by Mashhad University of Medical Sciences. Started Mar 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02254252.